These findings emphasize the critical and central role of IRF3 activation in inducing apoptosis in cancer cells following PARP7 inhibition, independent of the cell-type specific upstream signaling (i.e., RLR or cGAS/STING signaling). Here, DHX58 is linked to cancer.